| Zachary Mackay Tlumak, OD | |
|
950 Campbell Ave, West Haven, CT 06516-2770 | |
| (203) 932-5711 | |
| Not Available |
| Full Name | Zachary Mackay Tlumak |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 5 Years |
| Location | 950 Campbell Ave, West Haven, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881257004 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OEG004113 (Pennsylvania) | Secondary |
| 152W00000X | Optometrist | 3121 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wild Apple Eye Iii Llc | 5799177952 | 5 |
| Wild Apple Eye Llc | 6608296272 | 2 |
| Wild Apple Eye Ii Llc | 9537551353 | 5 |
News Archive
A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments conducted in animals infected with the delta variant have shown that CT-P59 is able to reduce symptom intensity and viral replication in the respiratory tract. The study is currently available on the bioRxiv* preprint server.
The U.S. Food and Drug Administration has approved Cymbalta® (duloxetine HCl; pronounced SIM-BALL-TA), judging it a safe and effective treatment for major depressive disorder, Eli Lilly and Company have announced.
Twice as many boys as girls are referred to medical specialists for evaluation of short stature or poor growth, according to a new study.
The first ever large-scale, longitudinal study of ketamine users has been published online today in the journal Addiction. With Ketamine (K, Special K) use increasing faster than any other drug in the UK (British Crime Survey, 2008) this research showing the consequences of repeated ketamine use provides valuable information for users and addiction professionals alike.
In the August 31 issue of Science Translational Medicine, new research from the University of Chicago shows how deficits in a specific pathway of genes can lead to the development of atrial fibrillation, a common irregular heartbeat, which poses a significant health risk.
› Verified 4 days ago
| Provider Name | Hebron Eye Care, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073729505 PECOS PAC ID: 9032131883 Enrollment ID: O20051221000570 |
News Archive
A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments conducted in animals infected with the delta variant have shown that CT-P59 is able to reduce symptom intensity and viral replication in the respiratory tract. The study is currently available on the bioRxiv* preprint server.
The U.S. Food and Drug Administration has approved Cymbalta® (duloxetine HCl; pronounced SIM-BALL-TA), judging it a safe and effective treatment for major depressive disorder, Eli Lilly and Company have announced.
Twice as many boys as girls are referred to medical specialists for evaluation of short stature or poor growth, according to a new study.
The first ever large-scale, longitudinal study of ketamine users has been published online today in the journal Addiction. With Ketamine (K, Special K) use increasing faster than any other drug in the UK (British Crime Survey, 2008) this research showing the consequences of repeated ketamine use provides valuable information for users and addiction professionals alike.
In the August 31 issue of Science Translational Medicine, new research from the University of Chicago shows how deficits in a specific pathway of genes can lead to the development of atrial fibrillation, a common irregular heartbeat, which poses a significant health risk.
› Verified 4 days ago
| Provider Name | Wild Apple Eye Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1104465939 PECOS PAC ID: 6608296272 Enrollment ID: O20201020002670 |
News Archive
A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments conducted in animals infected with the delta variant have shown that CT-P59 is able to reduce symptom intensity and viral replication in the respiratory tract. The study is currently available on the bioRxiv* preprint server.
The U.S. Food and Drug Administration has approved Cymbalta® (duloxetine HCl; pronounced SIM-BALL-TA), judging it a safe and effective treatment for major depressive disorder, Eli Lilly and Company have announced.
Twice as many boys as girls are referred to medical specialists for evaluation of short stature or poor growth, according to a new study.
The first ever large-scale, longitudinal study of ketamine users has been published online today in the journal Addiction. With Ketamine (K, Special K) use increasing faster than any other drug in the UK (British Crime Survey, 2008) this research showing the consequences of repeated ketamine use provides valuable information for users and addiction professionals alike.
In the August 31 issue of Science Translational Medicine, new research from the University of Chicago shows how deficits in a specific pathway of genes can lead to the development of atrial fibrillation, a common irregular heartbeat, which poses a significant health risk.
› Verified 4 days ago
| Provider Name | Wild Apple Eye Iii Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1346900412 PECOS PAC ID: 5799177952 Enrollment ID: O20220120000103 |
News Archive
A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments conducted in animals infected with the delta variant have shown that CT-P59 is able to reduce symptom intensity and viral replication in the respiratory tract. The study is currently available on the bioRxiv* preprint server.
The U.S. Food and Drug Administration has approved Cymbalta® (duloxetine HCl; pronounced SIM-BALL-TA), judging it a safe and effective treatment for major depressive disorder, Eli Lilly and Company have announced.
Twice as many boys as girls are referred to medical specialists for evaluation of short stature or poor growth, according to a new study.
The first ever large-scale, longitudinal study of ketamine users has been published online today in the journal Addiction. With Ketamine (K, Special K) use increasing faster than any other drug in the UK (British Crime Survey, 2008) this research showing the consequences of repeated ketamine use provides valuable information for users and addiction professionals alike.
In the August 31 issue of Science Translational Medicine, new research from the University of Chicago shows how deficits in a specific pathway of genes can lead to the development of atrial fibrillation, a common irregular heartbeat, which poses a significant health risk.
› Verified 4 days ago
| Provider Name | Wild Apple Eye Ii Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1174283246 PECOS PAC ID: 9537551353 Enrollment ID: O20220127001874 |
News Archive
A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments conducted in animals infected with the delta variant have shown that CT-P59 is able to reduce symptom intensity and viral replication in the respiratory tract. The study is currently available on the bioRxiv* preprint server.
The U.S. Food and Drug Administration has approved Cymbalta® (duloxetine HCl; pronounced SIM-BALL-TA), judging it a safe and effective treatment for major depressive disorder, Eli Lilly and Company have announced.
Twice as many boys as girls are referred to medical specialists for evaluation of short stature or poor growth, according to a new study.
The first ever large-scale, longitudinal study of ketamine users has been published online today in the journal Addiction. With Ketamine (K, Special K) use increasing faster than any other drug in the UK (British Crime Survey, 2008) this research showing the consequences of repeated ketamine use provides valuable information for users and addiction professionals alike.
In the August 31 issue of Science Translational Medicine, new research from the University of Chicago shows how deficits in a specific pathway of genes can lead to the development of atrial fibrillation, a common irregular heartbeat, which poses a significant health risk.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zachary Mackay Tlumak, OD 163 Broadway St, Colchester, CT 06415-1022 Ph: (860) 537-2020 | Zachary Mackay Tlumak, OD 950 Campbell Ave, West Haven, CT 06516-2770 Ph: (203) 932-5711 |
News Archive
A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments conducted in animals infected with the delta variant have shown that CT-P59 is able to reduce symptom intensity and viral replication in the respiratory tract. The study is currently available on the bioRxiv* preprint server.
The U.S. Food and Drug Administration has approved Cymbalta® (duloxetine HCl; pronounced SIM-BALL-TA), judging it a safe and effective treatment for major depressive disorder, Eli Lilly and Company have announced.
Twice as many boys as girls are referred to medical specialists for evaluation of short stature or poor growth, according to a new study.
The first ever large-scale, longitudinal study of ketamine users has been published online today in the journal Addiction. With Ketamine (K, Special K) use increasing faster than any other drug in the UK (British Crime Survey, 2008) this research showing the consequences of repeated ketamine use provides valuable information for users and addiction professionals alike.
In the August 31 issue of Science Translational Medicine, new research from the University of Chicago shows how deficits in a specific pathway of genes can lead to the development of atrial fibrillation, a common irregular heartbeat, which poses a significant health risk.
› Verified 4 days ago
Renitarul Sebastin, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711 | |
Dr. Crystal Lynn Deluca, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711 Fax: 203-479-8118 | |
Dr. Christopher M Inclima, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 415 Main St, West Haven, CT 06516 Phone: 203-934-5126 Fax: 203-932-2020 | |
Krystine Olszewski, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave, Va Ct Healthcare Systemc, West Haven, CT 06516 Phone: 203-932-5711 Fax: 203-937-3845 | |
Seymour Vision Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 343 Beach St Apt 506, West Haven, CT 06516 Phone: 707-318-3451 | |
Robert P Mingrone, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 153 Saw Mill Rd, West Haven, CT 06516 Phone: 203-934-1400 Fax: 203-933-6817 | |
Dr. Jordan Scott Zinn, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 950 Campbell Ave, Eye Clinic: Building 2 Floor 4, West Haven, CT 06516 Phone: 646-284-8591 |